Brief: Torrent Pharma- USFDA Has Issued Establishment Inspection Report For Indrad, Gujarat Facility
Torrent Pharmaceuticals Ltd TORP.NS :
* TORRENT PHARMA- USFDA HAS ISSUED ESTABLISHMENT INSPECTION
REPORT
FOR INDRAD, GUJARAT FACILITY
* TORRENT PHARMA - INSPECTION CONDUCTED BY USFDA FOR
MANUFACTURING
FACILITY AT INDRAD
* TORRENT PHARMA- INSPECTION HAS NOW BEEN SUCCESSFULLY
CLOSED BY
USFDA
* TORRENT PHARMA - USFDA ISSUED ESTABLISHMENT INSPECTION
REPORT
WITH VOLUNTARY ACTION INDICATED
Source text for Eikon: ID:nBSE6yKYHr
Further company coverage: TORP.NS
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says